Xavier Catteau

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Fully Automated Stain Quantification Framework for IHC Whole Slide Images in Breast Cancer.

Fully Automated Stain Quantification Framework for IHC Whole Slide Images in Breast Cancer.

Journal: Technology in cancer research & treatment

Published: April 03, 2026

Eosinophilic Cells in Endometrial Carcinoma as a Predictor of BRAF Mutation: Report of 2 Cases.

Eosinophilic Cells in Endometrial Carcinoma as a Predictor of BRAF Mutation: Report of 2 Cases.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: September 24, 2025

Descriptive study of stromal expression of CD73 in ductal carcinoma in situ of the breast.

Descriptive study of stromal expression of CD73 in ductal carcinoma in situ of the breast.

Journal: Discover oncology

Published: September 02, 2025

Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

Journal: Nature medicine

Published: July 18, 2025

First Case of Ovarian Metastases From a Primary Retroperitoneal Mucinous Carcinoma Associated With Teratoma, With KRAS and ERBB3 Mutations: Case Report and Literature Review.

First Case of Ovarian Metastases From a Primary Retroperitoneal Mucinous Carcinoma Associated With Teratoma, With KRAS and ERBB3 Mutations: Case Report and Literature Review.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: May 28, 2025

Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial.

Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial.

Journal: ESMO open

Published: February 12, 2025

Immunohistochemical Expression of RhoJ Protein in Breast Carcinoma.

Immunohistochemical Expression of RhoJ Protein in Breast Carcinoma.

Journal: Applied immunohistochemistry & molecular morphology : AIMM

Published: March 26, 2024

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Journal: Nature communications

Published: December 12, 2023

Comparison Between Manual and Automated Assessment of Ki-67 in Breast Carcinoma: Test of a Simple Method in Daily Practice.

Comparison Between Manual and Automated Assessment of Ki-67 in Breast Carcinoma: Test of a Simple Method in Daily Practice.

Journal: Technology in cancer research & treatment

Published: August 10, 2023

Inverse correlation between the amounts of lymphocytic infiltrate and stroma in breast carcinoma.

Inverse correlation between the amounts of lymphocytic infiltrate and stroma in breast carcinoma.

Journal: Heliyon

Published: August 07, 2023

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Journal: Nature communications

Published: July 27, 2023

Borderline phyllodes tumour of the breast with eosinophilic inclusion bodies: Case report and molecular sequencing.

Borderline phyllodes tumour of the breast with eosinophilic inclusion bodies: Case report and molecular sequencing.

Journal: International journal of surgery case reports

Published: July 10, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026